TEMOZOLOMIDE 20 mg (Temozolomide 20 mg)
Pill with imprint TEMOZOLOMIDE 20 mg is Orange & White, Capsule-shape and has been identified as Temozolomide 20 mg. It is supplied by IDT Australia Limited.
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEMOZOLOMIDE 20 mg
Temozolomide
- Imprint
- TEMOZOLOMIDE 20 mg
- Strength
- 20 mg
- Color
- Orange & White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- IDT Australia Limited
- National Drug Code (NDC)
- 64144-0502
- Inactive Ingredients
-
lactose anhydrous,
sodium starch glycolate type A potato,
silicon dioxide,
stearic acid,
tartaric acid,
gelatin,
methylparaben,
propylparaben,
sodium lauryl sulfate,
FD&C Yellow No. 6,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related Images for "TEMOZOLOMIDE 20 mg"
More about temozolomide
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 9 Reviews
- Drug class: alkylating agents
Consumer resources
- Patient Information
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
- Other brands
- Temodar
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.